Business Wire

Landmark SMART Study Demonstrates High Accuracy of Natera’s Panorama® NIPT for 22q11.2 Deletion Screening

When discussing the value of screening for 22q, the authors concluded that, “the PPV of cfDNA for 22q11.2DS is higher and the false positive rate is lower than that associated with other accepted ...
Business Wire

Natera Announces National Commercial Coverage for its Fetal RhD NIPT

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) and genetic testing, today announced a new policy for commercial coverage of its cfDNA Fetal RhD ...
Nasdaq

Myriad Genetics Unveils Groundbreaking Eight Weeks’ Gestation NIPT Study Results at Society for Maternal-Fetal Medicine Conference

SALT LAKE CITY, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced it will unveil groundbreaking research at ...
EurekAlert!

Genetic background of pregnant women can influence the result of the Non-Invasive Prenatal Test

Non-Invasive Prenatal Tests (NIPTs) are increasingly an integral part of screening during pregnancies across the world. Research from Amsterdam UMC shows that a pregnant woman's genetic background ...
News Medical

Yourgene Health and Genetix launch first local non-invasive prenatal testing service in Colombia

We strive to advance diagnostic services and transform prenatal genetics in our country, and the launch of the NipTest is a testament to this. Yourgene’s quality-assured IONA Nx NIPT Workflow empowers ...